LitAlert ~~ GeneLit.com

    • Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations.
    • Ahearn TU, Pal Choudhury P, Derkach A, Wiafe-Addai B, Awuah B, Yarney J, Edusei L, Titiloye N, Adjei E, Vanderpuye V, Aitpillah F, Dedey F, Oppong J, Osei-Bonsu EB, Duggan MA, Brinton LA, Allen J, Luccarini C, Baynes C, Carvalho S, Dunning AM, Davis Lynn BC, Chanock SJ, Hicks BD, Yeager M, Chatterjee N, Biritwum R, Clegg-Lamptey JN, Nyarko K, Wiafe S, Ansong D, Easton DF, Figueroa JD, Garcia-Closas M.
    • Cancer Epidemiol Biomarkers Prev. 2022 Jun 2:cebp.EPI-21-1397-E.2021-12-9 11:31:59.213. doi: 10.1158/1055-9965.EPI-21-1397. Epub ahead of print.
    • Association between ancestry-specific 6q25 variants and breast cancer subtypes in Peruvian women.
    • Zavala VA, Casavilca-Zambrano S, Navarro Vásquez J, Castañeda CA, Valencia G, Morante Z, Calderón M, Abugattas JE, Gomez H, Fuentes HA, Liendo-Picoaga R, Cotrina JM, Monge C, Neciosup SP, Huntsman S, Hu D, Sanchez SE, Williams MA, Nunez-Marrero A, Godoy L, Hechmer A, Olshen AB, Dutil J, Ziv E, Zabaleta J, Gelaye B, Vasquez J, Galvez-Nino M, Enriquez-Vera D, Vidaurre T, Fejerman L.
    • Cancer Epidemiol Biomarkers Prev. 2022 Jun 2:cebp.EPI-22-0069-A.2022-1-20 15:23:11.350. doi: 10.1158/1055-9965.EPI-22-0069. Epub ahead of print.
    • BRCA variants do not increase the risk of adverse reactions in patients with ovarian cancer: A single-center real-world study.
    • LI K, Zeng J, Zhang M, Yin R, Li Z.
    • Front Oncol. 2022 Jun 2;12:807748. doi: 10.3389/fonc.2022.807748.
    • DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries.
    • Abdi B, Basset N, Perrot E, Benderra MA, Khalil A, Oudard S, Blanchet P, Brureau L, Coulet F, Cussenot O, Cancel-Tassin G.
    • Prostate. 2022 Jun 2. doi: 10.1002/pros.24374. Epub ahead of print.
    • The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
    • Liu AJ, Kosiorek HE, Ueberroth BE, Jaeger E, Ledet E, Kendi AT, Tzou K, Quevedo F, Choo R, Moore CN, Ho TH, Singh P, Keole SR, Wong WW, Sartor O, Bryce AH.
    • Prostate. 2022 Jun 2. doi: 10.1002/pros.24375. Epub ahead of print.
    • Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series.
    • Zhao L, Singh V, Ricca A, Lee P.
    • J Med Cases. 2022 May;13(5):240-243. doi: 10.14740/jmc3918. Epub 2022 May 7.